ALLODX
Clinical Research
An Exploratory dd-cfDNA Cutoff in a Chinese Heart Transplant Cohort: Results from a Prospective Study at Fuwai Hospital
A prospective study of 80 recipients and 299 plasma samples established an exploratory dd-cfDNA cutoff of 0.33% (AUC 0.874) for detecting acute rejection in a Chinese heart transplant cohort. AlloDx…
Read more ↗
AlloDx makes new progress in non-invasive research on bladder cancer based on urine cfDNA copy number variation analysis
Bladder cancer is one of the common malignant tumors worldwide. Currently, its clinical diagnosis mainly relies on invasive methods such as cystoscopy. Although it has diagnostic value, it has…
Read more ↗
High-resolution HLA genotyping technology helps improve transplant matching accuracy
The AlloDx R&D team, together with the Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University and the School of Life Sciences of Jiangsu University, successfully broke through the…
Read more ↗
Professor Wang Rending’s team from the First Hospital of Zhejiang University discovered a new marker for monitoring BKV nephropathy: simultaneous measurement of urine and plasma dd-cfDNA can assist in the adjustment of immunosuppressants in kidney transplant patients
Professor Wang Rending’s team from the First Affiliated Hospital of Zhejiang University School of Medicine has recently made important scientific research breakthroughs. A prospective cohort study…
Read more ↗
Scientific research results | Clinica Chimica Acta published an article: A new non-invasive BK virus-related nephropathy detection technology
Recently, AlloDx (AlloDx Biotech), together with Jiangsu University, Tongji Hospital Affiliated to the School of Medicine of Huazhong University of Science and Technology and other institutions,…
Read more ↗
Scientific research results | The research results related to AlloDx donor-derived cell-free DNA were published in Kidney Research and Clinical Practice magazine
Recently, AlloDx conducted another study on donor-derived cell-free DNA, "Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejec
Read more ↗
Scientific research results | AlloDx's research article on the analysis of factors affecting the detection of donor-derived cell-free DNA is officially published
Recently, an important result of the AlloDx research team - Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplant
Read more ↗
Research in the Journal of Zhejiang University Identifies a Biomarker to Distinguish BKVAN from TCMR
With the use of highly effective immunosuppressants, infection after kidney transplantation is one of the main problems faced by patients, especially BK virus-related nephropathy, which is one of the…
Read more ↗
dd-cfDNA is a biomarker for accurate diagnosis of kidney transplant antibody-mediated rejection (ABMR)
Recently, the Kidney Disease Center of the Eastern Theater Command General Hospital cooperated with the AlloDx Medical Department to use AlloDx AlloK seqTM [Ankang] non-invasive detection platform…
Read more ↗
A Nature Portfolio Journal Cites the AlloDx Team's Early dd-cfDNA Research
Recently, the AlloDx team's early paper on the detection technology of kidney transplant donor-derived cell-free DNA (dd-cfDNA) was cited once by a Nature sub-journal published in May.
Read more ↗
Published by Clinical Transplantation | The value of dd-cfDNA in evaluating acute rejection treatment
Recently, important research results jointly conducted by Professor Wang Rending’s team at the Kidney Disease Center of the First Affiliated Hospital of Zhejiang University and AlloDx Medical…
Read more ↗
Transplantation Proceedings | AlloDx joins hands with domestic organ transplant experts to develop a new method for detecting postoperative rejection and infection in organ transplant patients
In September 2019, the research results on a new method for detecting rejection and infection in organ transplant patients, jointly led by the School of Life Sciences of Jiangsu University, the…
Read more ↗
[Published by TRANSPL INT] The first domestic post-transplant liquid biopsy data published
Recently, "Transplant International", a well-known international journal in the field of transplantation, published online a study conducted by our company and the team of Director Wang Rending of…
Read more ↗
AlloDx Kidney Transplant dd-cfDNA Research Cited in a Nature Portfolio Journal
As a central collaborating unit, early papers by the AlloDx team on donor-derived cell-free DNA (dd-cfDNA) testing technology for kidney transplantation were cited once by a Nature sub-journal published in May. AlloDx was among the early to perform kidney transplant donor-derived dd-cfDNA testing; related technical papers have been cited by international authoritative journals.
Read more ↗No matching content. Try another keyword or view all categories.